trolamine salicylate has been researched along with Hypertension, Renovascular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, D; Chen, J; Luo, X; Wang, Y; Wei, W; Wu, H; Xu, Z; Yan, S; Zhang, Y; Zhou, Y | 1 |
1 other study(ies) available for trolamine salicylate and Hypertension, Renovascular
Article | Year |
---|---|
2K1C-activated Angiotensin II (Ang II) exacerbates vascular damage in a rat model of arthritis through the ATR/ERK1/2 signaling pathway.
Topics: Angiotensin II; Animals; Arthritis; Ataxia Telangiectasia Mutated Proteins; Blood Pressure; Blood Vessels; Capillary Tubing; Cell Movement; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Hypertension, Renovascular; Male; MAP Kinase Signaling System; NF-kappa B; Rats; Rats, Sprague-Dawley | 2017 |